CD302 expressed predominantly in myeloid than lymphoid compartment. (A) The landscape of CD302⁺ protein expression across stem and progenitor cells and myeloid and lymphoid cells by flow cytometry. (B) The correlation between CD302⁺CD45⁺ selected MNCs and CD302⁺ myeloid cells (CD33⁺CD11b⁺). (C) The correlation between CD302⁺CD45⁺ selected MNCs and CD302⁺ lymphoid cells (CD33⁻CD11b⁻CD3⁺/CD19/⁺CD56⁺). (D) The box plot shows the frequency of CD302⁺ on myeloid cells by flow cytometry in PR (PR-1 and PR-2) and GR groups. (E) The box plot shows the frequency of CD302⁺ on lymphoid cells by flow cytometry in PR-1, PR-2, and GR groups.